Navigation Links
IMPLANET Raises Additional EUR 8 Million (USD 11 Million) to Fuel Deployment
Date:4/26/2010

BORDEAUX, France, April 26, 2010 /PRNewswire/ -- Thanks to promising commercial debut of its products (Surgical implants for Orthopedic and Spine surgery) and its Healthcare Information Technologies service offer (fully integrated and automated patient/product tracking and supply chain) IMPLANET S.A. raises an additional EUR 8 million (USD 11 million).

IMPLANET is proud to welcome a reference new institutional investor, CM-CIC Private Equity which brings EUR 4 million.

Led by Edmond de Rothschild Investment Partners, historical shareholders, Wellington Partners, Seventures Partners et Auriga Partners along with founders, management and several domain reference private investors such as Marie-Helene PLAIS-COTREL (ex Sofamor-Danek) continue to support IMPLANET since inception in 2007 and together provide EUR 4 million.

Erick CLOIX (CEO IMPLANET) declares: "This new round of financing concludes a first cycle of 3 years during which 30 million Euros were invested to prepare and develop a novel type of Healthcare Company addressing, at last, the paradigm shifting challenges of quality, security and financing of healthcare everywhere, particularly in Europe and the USA. The current economic and financial crisis along with the US health care reform in the USA is a catalyst for our technologies, our services and our business model. The new 2010-2012 cycle which opens for us looks formidable with opportunities and conquests."

About Implanet

Implanet is a Medical Device and Healthcare Information Technology company based in Bordeaux, France. IMPLANET was incorporated in early 2007 and currently employs 45 full time employees and is already present within 8 countries. IMPLANET designs and manufactures surgical implants (HIP, KNEE, SPINE, and ARTHROSCOPY) exclusively in France and in Europe. These products are tested and registered under CE & FDA guidelines and standards by independent US and French registered testing laboratories. IMPLANET designs and develops unique healthcare information technologies applications for the tracking and tracing of Medical devices/Drugs and patients as well as healthcare supply chain optimization for both suppliers and hospitals under the brand name BEEP N TRACK . IMPLANET is also sole proprietor of various invention patents in France, Europe the USA and Asia on its surgical products and its Information Technologies.

    http://www.implanet.com/shareholder/levee_fond_en.pdf
    http://www.implanet.com
    http://www.beepntrack.com
    http://www.edrip.fr


'/>"/>
SOURCE IMPLANET
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Intercept Pharmaceuticals Raises $25 Million Series B Financing
2. The Oclaro Next-Generation Orion Fiber-Coupled Diode Laser Raises the Bar for Performance, Cost and Reliability for Solid State Lasers
3. Circassia Raises GBP15 Million ($25 Million) in Oversubscribed Investment Round
4. Apnex Medical, Inc. Raises Additional $14 Million
5. Cambridge-based Ligon Discovery Raises $1M in Seed Funding
6. FREE Drug Discount Card Saves Money on Prescriptions and Raises Funds for Americas Disabled Veterans
7. CareFusion Reports First Quarter Results, Raises Full-Year Outlook
8. NxStage(R) Reports Third Quarter 2009 Financial Results and Raises Revenue Guidance for Fiscal 2009
9. Cancer Diagnostics Company, On-Q-ity, Raises $21M in Series A Funding for the Development of Technologies to Personalize Cancer Therapy
10. Xanodyne Raises $50 Million in Equity Financing to Support Emerging Product Portfolio
11. Biocartis Raises EUR10 Million in Series A Financing Round
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... Avillion LLP, a co-developer and financier of late-stage pharmaceutical ... MBA as Chief Medical Officer. Dr Weinberg will be based in ... ... more than 17 years as a pharmaceutical and biotech executive with ... the course of his career, he has interfaced with the US ...
(Date:1/19/2017)... YORK , Jan. 19, 2017 The ... provides understanding and access to partnering deals and agreements ... - Trends in partnering deals - Top deals by ... stage of development, technology type The report provides ... entered into by the world,s leading healthcare companies. ...
(Date:1/19/2017)... 19, 2017 This report on the opioid ... scenario of the global market. Large number of chronic ... chronic constipation is a major side effect of consumption ... novel targeted therapy has been prescribed to treat opioid ... targeted medicines, and growing awareness about the therapy are ...
Breaking Medicine Technology:
(Date:1/20/2017)... ... , ... Source Vitál Apothecary, a skin and body care company dedicated to ... had a successful visit to the 2017 ECRM Diet, Vitamin & Sports Nutrition Conference ... the nutritional, sports and health industries a chance to meet in private sessions with ...
(Date:1/20/2017)... ... January 20, 2017 , ... Lice Troopers, the lice ... in families with school-aged children since the holiday season. , “It happens every ... their families, sharing hugs and taking photos, which is the head-to-head gateway that lice ...
(Date:1/20/2017)... boca raton florida (PRWEB) , ... January 20, 2017 , ... ... trial at the Dana Farber Cancer Institute. For Betsy, the clinical trial has ... and her cancer has not worsened. , Betsy Brauser was diagnosed with ovarian ...
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... “Mary Magdalene: ... the mysterious life of the woman who witnessed Jesus Christ firsthand. “Mary Magdalene: Grace ... denizen, who spent her career as an educator interacting with countless women who had ...
(Date:1/20/2017)... ... January 20, 2017 , ... “I Forgive You”: a fine examination of how ... You” is the creation of published author, Stephen Miller, who, for over ten long years ... given to him. Born in Trinidad and Tobago, he has been serving the Lord for ...
Breaking Medicine News(10 mins):